Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hematologic Diseases × Immunotherapy, Adoptive × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Non-Hodgkin 6 Lymphoma, B-Cell 6 Recurrence 4 Multiple Myeloma 4 Lymphoma 3 Leukemia, Myeloid, Acute 3 Lymphoma, Follicular 2 Leukemia 2 Burkitt Lymphoma 2 Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Pyloric Stenosis, Hypertrophic 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Platinum-Resistant Ovarian Carcinoma 1 Plasmacytoma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Neoplasm, Residual 1 Nasopharyngeal Carcinoma 1 Myelodysplastic Syndromes 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell, Marginal Zone 1

Interventions

venetoclax 1 pirtobrutinib 1 nirogacestat 1 ibrutinib 1 fludarabine phosphate 1 cedazuridine 1 Watchful Waiting 1 Vital Signs 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Lenalidomide 1 Immunotherapy, Adoptive 1 Filgrastim 1 Dexamethasone 1 Cyclophosphamide 1 Bone Marrow Transplantation 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04180059 2026-01-26

CTL-DP 01

Nantes University Hospital

Phase 1 Recruiting

Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡